今年は昨年の35演題を超える43演題が採択されました。
| No | 演題 | 演者 |
|---|---|---|
| 1 | Attenuated response of plasma B-type Natriuretic Peptide under High Serum Sodium Concentration in Patient with Cardiovascular Disease | Aizawa T |
| 2 | Midterm Clinical and Angiographic Outcomes after Everolimus-elutingStents Placement for First STEMI: Propensity Score-MatchedComparisons with Bare-metal and Paclitaxel-eluting Stents | Ishikawa T |
| 3 | The Curved Esophagus in Patients with Atrial Fibrillation. | Isogai R |
| 4 | Relationship Between Intracoronary Pressure Wire Value and Cardiac Function at Coronary Artery Disease | Itakura R |
| 5 | A Highly Sensitive Regulatory System of Plasma B-type Natriuretic Peptide to Ischemic Heart | Itakura R |
| 6 | Collaborative Activities of Noradrenaline and Natriuretic Peptide forGlucose Utilization in Patients with ACS According to | Uno G |
| 7 | Impact of Touch-up Ablation on Outcomes after Cryoballoon Ablation for Atrial Fibrillation | Oseto H |
| 8 | The Relation between Clinical Characteristics and Termination of Atrial Tachyarrhythmias by Anti-Tachycardia in Patients with Implantable Cardiac Devices | Okajima E |
| 9 | Predictors of Oxygenation Impairment in Acute Type B Aortic Dissection | Kashiwagi Y |
| 10 | Thermogenic Action of B-type Natriuretic Peptide in Patients with Cardiovascular Diseases According to Covariance Structure Analysis | Kang R |
| 11 | Natriuretic Peptide Exerts Thermogenic Effects on Brown Adipocytes in a Low-Temperature-Sensitive Manner: Direct Measurement of Intracellular Temperature Using Fluorescent Thermoprobe | Kimura H |
| 12 | Increased Levels of Cardiac Troponin I in Subjects with Extremely Low B-type Natriuretic Peptide Levels | Sugawa S |
| 13 | Nutritional indexes can predict short-term mortality in hospitalized heart failure patients. | Suzuki K |
| 14 | Long Term Outcomes of Cryoballoon vs. Radiofrequency Ablation forParoxysmal Atrial Fibrillation. Propensity Score Matched Analysis. | Tokuda M |
| 15 | Lesson from Radiofrequency Catheter Ablation of Atrial Fibrillationfrom 2002 to 2016: Did we improve? | Tokuda M |
| 16 | Repeat Ablation for Very Late Recurrence of Atrial Fibrillation afterRadiofrequency Catheter Ablation: Electrophysiological Findings andLong-term Outcomes | Tokuda M |
| 17 | Radiofrequency Needle for Transseptal Puncture Reduces the Risk ofThromboembolism during Catheter Ablation of Atrial Fibrillation:Propensity score matched analysis | Tokuda M |
| 18 | Catheter Ablation for Atrial Fibrillation in Patients with Persistent LeftSuperior Vena Cava | Tokutake K |
| 19 | Subclavian Vein Pacing for Phrenic Nerve Monitoring duringCryoballoon Ablation of Atrial Fibrillation | Tokutake K |
| 20 | Anatomic Characteristic of Pulmonary Veins Stenosed after Cryoballoon Pulmonary Vein Ablation | Tokutake K |
| 21 | Impact of Continuation of Anti-arrhythmic Drugs during the Periprocedural Period on Recurrence of Atrial Fibrillation following Catheter Ablation | Narui R |
| 22 | Comparison of Pulmonary Vein Reconnection after Cryoballoon orOpen Irrigated Radiofrequency Ablation for Paroxysmal AtrialFibrillation | Narui R |
| 23 | Continuation of Anti-arrhythmic Drugs through the PeriproceduralPeriod of Catheter Ablation in Patients with Persistent AtrialFibrillation | Narui R |
| 24 | Prevalence and Characteristics of Late Gadolinium Enhancement of Cardiac MRI in Fabry patients | Nojiri A |
| 25 | A Case of Cardiac Tumor showing a Fulminant Myocarditis-like Course | Nomura A |
| 26 | Relationship between Aggravation of Lipid Oxidation and Low Plasma B-type Natriuretic Peptide in Patients with Cardiovascular Disorders. | Hasegawa J |
| 27 | Successful treatment of pulmonary arterial hypertension with thalidomide in patient with POEMS syndrome | Hiraki N |
| 28 | An Inverse Association between Valvular Heart Disease and AcuteCoronary Syndrome; B-type Natriuretic Peptide as a PossibleInterjacent Factor | Fukumoto R |
| 29 | Long-term Beneficial Effect of Enzyme Replacement Therapy in Fabry Patients | Hongo K |
| 30 | Termination of Atrial Tachyarrhythmia by Reactive ATP: Whichtachycardia and which pacing? | Matsuo S |
| 31 | Durable Pulmonary Vein Isolation with Guide of The Novel Indicator"Lesion Size Index" | Matsuo S |
| 32 | The Novel Index including Contact Force, Time and RadiofrequencyPower for Pulmonary Vein Isolation in Patients with Atrial Fibrillation | Matsuo S |
| 33 | Regulation of Left Ventricular Function by Basal Coronary Tonus; a Study with Patients Undergoing Acetylcholine Provocation Test of Coronary Spasm | Minai K |
| 34 | Relationship between Stress Hyperglycemia and Early Onset Time isimplicated in Mortality of | Mori C |
| 35 | Characteristics of Electrocardiogram in Patients Newly Diagnosed with Fabry Disease | Morimoto S |
| 36 | Electrophysiological Features on the Critical Isthmus of ReentrantAtrial Tachycardia: Assessment with Ultra High-resolution Mapping | Yamashita S |
| 37 | Novel Stepwise Ablation for Non-paroxysmal Atrial Fibrillation | Yamashita S |
| 38 | Catheter Ablation in Persistent Atrial fibrillation Patients withCongestive Heart Failure | Yamashita S |
| 39 | Long-term Clinical Outcome After Catheter Ablation for PersistentAtrial Fibrillation: Linear vs. CFAE Ablation | Yamashita S |
| 40 | Clinical Factors Associating with Atrial Fibrillation Recurrence After Catheter Ablation: Sex Differences in Electrophysiology | Yamashita S |
| 41 | Midterm Clinical and Angiographic Outcomes of Current Advanced-limus-eluting Stents for Patients with Hemodialysis – RetrospectiveComparisons with Paclitaxel-eluting Stents – | Yamada T |
| 42 | Very Early Recurrence is not Associated with True Recurrence ofAtrial Fibrillation after Cryoballoon Ablation | Yokoyama K |
| 43 | No Harmful Effects of a Selective SGLT2-inhibitor in contrast to Impairment of Cardiac Energy Metabolism by Phlorizin during Ischemia-Reperfusion Injury | Yoshii A |